HC Banking to Large Pharma/Biotech back to HC Banking/PE
Here is an idea that I have been throwing around lately. Currently, I'm a first year analyst at a boutique investment bank. My group is focused on healthcare/biotech, which I love. I'm curious to see if anyone has made the transition from banking to a finance related position (or another position) within a fortune 100 company, it doesn't have to be HC related. I have some really solid connections at Big Pharma/Big Biotech that I know would give me a position relating to finance within their organization, potentially on their internal M&A team.
I say this because I think it would be a great experience for when I go to apply to b-school. I also think it would give me credibility coming out of b-school, should I want to jump into a HC focused PE shop. I think industry experience at the corporate level would provide significant value when returning to HC focused Banking/PE.
Also, if you believe it would be more valuable to take on a position outside of the finance realm within a F100 please state your opinion.
Thank you so much for the feedback.
I would love to hear comments about this too. I will be starting as a first year analyst in a BB healthcare group, and I'm thinking 2-3 years IB, 2 years biotech PE/VC and then corporate M&A in Big Pharma/Biotech.
Qui ab error consequuntur velit quia. Vero voluptates hic consectetur tempore voluptate quia. Eius corporis consequatur quia nihil voluptatem. Quibusdam at explicabo nihil.
Et quos distinctio porro dolorem. Ipsam illo temporibus doloremque libero et qui fuga.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...